Mining the melanosome for tumor vaccine targets: P. polypeptide is a novel tumor-associated antigen

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8100-8104

  Touloukian, C E ^a   Leitner, W W ^a   Robbins, P F ^a   Rosenberg, S A ^a   Restifo, N P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; MEMBRANE PROTEIN; P POLYPEPTIDE; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE GUN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MELANOCYTE; MELANOMA; MELANOSOME; MOLECULAR RECOGNITION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; EPITOPES, T-LYMPHOCYTE; H-2 ANTIGENS; HLA-A ANTIGENS; HUMANS; MELANOMA; MELANOSOMES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; RNA, MESSENGER;

EID: 0035890576     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma
2. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
3. An autologous oral DNA vaccine protects against murine melanoma
4. Melanoma biology and progression
5. Adoptive T cell immunotherapy of human uveal melanoma targeting gp100
6. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
7. gp100/pmel 17 is a murine tumor rejection antigen: Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand
8. Escape of human solid tumors from T cell recognition: Molecular mechanisms and functional significance
9. + T cell responses
10. + T lymphocytes
11. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
12. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
13. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
14. The mouse pink-eyed dilution gene: Association with human Prader-Willi and Angelman syndromes
15. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism
16. Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens
17. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy
18. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes
19. DNA and RNA-based vaccines: Principles, progress and prospects
20. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose
21. + T cells without selection of higher affinity TCR